American Gene Technologies International Inc. (AGT)

A private biotechnology company developing cures and treatments
for Infectious diseases, cancers and monogenic disorders.

Corporate Profile

AGT, has a broad, robust lentiviral delivery platform evolved over ten years of advanced development. AGT has an extensive and growing patent portfolio surrounding its lentiviral platform innovations that accelerate the development of a wide variety of drug candidates. This platform allows AGT to pursue exciting clinical “cures” in large and orphan indications and complex diseases. AGT’s proprietary platform technologies provide reusable components that allow AGT and its internationally recognized collaborators to create new therapies in a fraction of the time of traditional drug development processes and other drug companies. AGT is expecting to begin clinical trials this year for an HIV cure based on a successful pre-IND meetings with the FDA.

AGT has built a rich product pipeline of genetic therapies for patients suffering from infectious disease, monogenic disorders, and cancer, using its lentiviral vector platform and patented methods.



Load More (6)

Press Releases

Load More (26)

Latest AGT Tweets

1 day ago
We're excited for tonight's @MDTechCouncil Industry Awards! Thank you MTC and our colleagues for recognizing @AmericanGene as a finalist for #LifeSciences Company of the Year and @JeffreyGalvin as #CEO of the Year. All nominees are winners.

#biotech #genetherapy #makeanimpact
americangene photo
2 days ago
HIV Cure Program Patent Granted To American Gene Technologies.
☞ Read press release:

#genetherapy #biotech #HIV
americangene photo
4 days ago
My week on Twitter 🎉: 47 Likes, 4 Retweets, 4.63K Retweet Reach, 17 New Followers. See yours with americangene photo